Liver international : official journal of the International Association for the Study of the Liver · 2025
Identification and Retrieval of Untreated HCV-Infected Individuals Lost to Follow-Up in Italy: Results From the RECALL Project.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Conti Fabio, Vittoria Agnese Della, Liverani Elisa, Briganti Elisabetta, Di Cesare Simona, Tirotta Daniela, Larnè Damiano, Fabbri Angela, Grassi Alberto, Bassi Paolo, Cristini Francesco, Fabbri Carlo, Muratori Paolo, Biagetti Carlo, Secomandi Alice, Napoli Lucia, Borghi Alberto, Alemanni Luigina Vanessa, Gianfreda Romina, Angelini Raffaella, Reali Chiara, Bakken Elizabeth, Cricca Monica, Sambri Vittorio, Ballardini Giorgio, Foschi Francesco Giuseppe
Аннотация
BACKGROUND AND AIMS: Despite the availability of highly effective direct-acting antivirals, undiagnosed and untreated hepatitis C virus (HCV) infections remain a major obstacle to achieving WHO elimination targets. This study evaluated the feasibility and effectiveness of a local micro-elimination initiative aimed at identifying, retrieving and re-linking previously diagnosed but not treated individuals.
METHODS: A retrospective analysis of anti-HCV test records from 2014 to 2020 in the AUSL Romagna area identified all individuals with a positive anti-HCV test and either confirmed or possible chronic HCV infection. Eligible cases were prospectively contacted first by phone, then by letter, and invited for clinical reassessment and antiviral therapy evaluation.
RESULTS: Among 6859 individuals with a previous positive anti-HCV test, 2719 were identified as potentially viremic. Of these, 704 met eligibility criteria and were contacted. A total of 485 individuals were successfully reached (68.9%), 214 attended clinical reassessment and 160 were found to have active infection. Antiviral therapy was initiated in 127 patients (79.4%), with 100% achieving sustained virologic response. Advanced fibrosis or cirrhosis was present in 18.7%, and hepatobiliary malignancies were newly diagnosed in four patients.
CONCLUSIONS: This targeted retrieval strategy demonstrates that re-linkage of previously diagnosed HCV patients lost to follow-up is feasible and effective. Scaling up similar structured program could significantly contribute to national HCV elimination efforts by recovering hidden reservoirs of infection.
METHODS: A retrospective analysis of anti-HCV test records from 2014 to 2020 in the AUSL Romagna area identified all individuals with a positive anti-HCV test and either confirmed or possible chronic HCV infection. Eligible cases were prospectively contacted first by phone, then by letter, and invited for clinical reassessment and antiviral therapy evaluation.
RESULTS: Among 6859 individuals with a previous positive anti-HCV test, 2719 were identified as potentially viremic. Of these, 704 met eligibility criteria and were contacted. A total of 485 individuals were successfully reached (68.9%), 214 attended clinical reassessment and 160 were found to have active infection. Antiviral therapy was initiated in 127 patients (79.4%), with 100% achieving sustained virologic response. Advanced fibrosis or cirrhosis was present in 18.7%, and hepatobiliary malignancies were newly diagnosed in four patients.
CONCLUSIONS: This targeted retrieval strategy demonstrates that re-linkage of previously diagnosed HCV patients lost to follow-up is feasible and effective. Scaling up similar structured program could significantly contribute to national HCV elimination efforts by recovering hidden reservoirs of infection.